Steven M Lanham

Title: Steven M. Lanham: Innovator in Diagnostic Assays

Introduction

Steven M. Lanham, a notable inventor based in Brownsburg, Indiana, has made significant contributions to the field of diagnostics. His work focuses on enhancing the efficiency and accuracy of biological assays, an area that holds great importance in medical testing and research.

Latest Patents

Steven holds one patent, which is titled "Reagent composition and assay for the determination of .gamma.-glutamyltransferase activity in biological specimens." This innovative patent describes an improved diagnostic assay and a stabilized reagent composition that utilizes a buffered solution of .gamma.-glutamyl-p-nitroanilide and glycylglycine. The addition of .beta.-cyclodextrin and dimethylsulfoxide enhances the effectiveness of the assay, thereby providing a more reliable method for measuring enzyme activity in biological samples.

Career Highlights

Steven is associated with American Monitor Corporation, where he applies his expertise to develop advancements in diagnostic technologies. His dedication to his work ensures that the company remains at the forefront of innovation in the medical diagnostics sector.

Collaborations

At American Monitor Corporation, Steven collaborates closely with his coworker, Larry E. Beaty. Together, they work on pioneering projects that push the boundaries of current diagnostic methodologies, contributing to the broader scientific community.

Conclusion

Steven M. Lanham's innovative contributions to diagnostic assays reflect his commitment to improving healthcare solutions. His research not only exemplifies individual excellence but also highlights the collaborative spirit within American Monitor Corporation, aiming for advancements that benefit both the industry and society.